Today’s Stock Alert: Novadaq Technologies Inc. Can’t Be More Risky. Trades Sigfnicicantly Lower

Today's Stock Alert: Novadaq Technologies Inc. Can't Be More Risky. Trades Sigfnicicantly Lower

The stock of Novadaq Technologies Inc. (NASDAQ:NVDQ) is a huge mover today! About 438,206 shares traded hands or 78.56% up from the average. Novadaq Technologies Inc. (NASDAQ:NVDQ) has declined 25.63% since April 13, 2016 and is downtrending. It has underperformed by 29.56% the S&P500.
The move comes after 8 months negative chart setup for the $510.07 million company. It was reported on Nov, 15 by We have $7.89 PT which if reached, will make NASDAQ:NVDQ worth $25.50M less.

Novadaq Technologies Inc. (NASDAQ:NVDQ) Ratings Coverage

Out of 4 analysts covering Novadaq Technologies Inc (NASDAQ:NVDQ), 4 rate it a “Buy”, 0 “Sell”, while 0 “Hold”. This means 100% are positive. Novadaq Technologies Inc has been the topic of 6 analyst reports since October 7, 2015 according to StockzIntelligence Inc. The firm earned “Outperform” rating on Wednesday, October 7 by Wedbush. The stock of Novadaq Technologies Inc. (NASDAQ:NVDQ) has “Mkt Outperform” rating given on Wednesday, January 6 by JMP Securities. The rating was upgraded by First Analysis on Thursday, October 29 to “Overweight”.

According to Zacks Investment Research, “Novadaq Technologies Inc. develops, manufactures and markets real-time fluorescence imaging products for use in the operating room and other clinical settings. The company’s key markets include plastic reconstructive, gastrointestinal, cardiac and general surgery. It provides SPY imaging systems which enables surgeons to the visualize blood flow in vessels, co-joined vessels and micro-vessels. Novadaq Technologies Inc. is headquartered in Mississauga, Canada.”

Another recent and important Novadaq Technologies Inc. (NASDAQ:NVDQ) news was published by which published an article titled: “/quotes/zigman/3870025/realtime” on March 05, 2012.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Leave a Comment